These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37562893)

  • 1. Critical illness-associated weakness and related motor disorders.
    Younger DS
    Handb Clin Neurol; 2023; 195():707-777. PubMed ID: 37562893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].
    Judemann K; Lunz D; Zausig YA; Graf BM; Zink W
    Anaesthesist; 2011 Oct; 60(10):887-901. PubMed ID: 22006117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular involvement in COVID-19 critically ill patients.
    Cabañes-Martínez L; Villadóniga M; González-Rodríguez L; Araque L; Díaz-Cid A; Ruz-Caracuel I; Pian H; Sánchez-Alonso S; Fanjul S; Del Álamo M; Regidor I
    Clin Neurophysiol; 2020 Dec; 131(12):2809-2816. PubMed ID: 33137571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis.
    Latronico N; Bolton CF
    Lancet Neurol; 2011 Oct; 10(10):931-41. PubMed ID: 21939902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical illness polyneuropathy and myopathy in the intensive care unit.
    Zink W; Kollmar R; Schwab S
    Nat Rev Neurol; 2009 Jul; 5(7):372-9. PubMed ID: 19578344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuromuscular manifestations in critically ill patients].
    Smith TA; Fabricius ME
    Ugeskr Laeger; 2007 Jun; 169(23):2216-9. PubMed ID: 17592690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intensive care unit-acquired weakness: development of polyneuropathy and myopathy in critically ill patients].
    Takei T
    Brain Nerve; 2014 Feb; 66(2):161-70. PubMed ID: 24523314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes.
    Latronico N; Rasulo FA; Eikermann M; Piva S
    Crit Care; 2023 Nov; 27(1):439. PubMed ID: 37957759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.
    Apostolakis E; Papakonstantinou NA; Baikoussis NG; Papadopoulos G
    J Anesth; 2015 Feb; 29(1):112-21. PubMed ID: 24981564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neurophysiological characterization of muscular weakness in severe COVID-19.
    Bax F; Lettieri C; Marini A; Pellitteri G; Surcinelli A; Valente M; Budai R; Patruno V; Gigli GL
    Neurol Sci; 2021 Jun; 42(6):2173-2178. PubMed ID: 33755815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical review: Critical illness polyneuropathy and myopathy.
    Hermans G; De Jonghe B; Bruyninckx F; Van den Berghe G
    Crit Care; 2008; 12(6):238. PubMed ID: 19040777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICU-acquired weakness.
    Schweickert WD; Hall J
    Chest; 2007 May; 131(5):1541-9. PubMed ID: 17494803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical illness polyneuropathy and myopathy].
    Motomura M
    Rinsho Shinkeigaku; 2003 Nov; 43(11):802-4. PubMed ID: 15152469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The General Weakness Syndrome Therapy (GymNAST) study: protocol for a cohort study on recovery on walking function.
    Mehrholz J; Mückel S; Oehmichen F; Pohl M
    BMJ Open; 2014 Oct; 4(10):e006168. PubMed ID: 25344484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived utility of electrodiagnostic testing in critical illness myopathy and polyneuropathy: A survey of intensive care unit providers.
    Isfort M; McVerry BJ; Shutter L; Kim M; Lacomis D
    Muscle Nerve; 2022 Jul; 66(1):90-95. PubMed ID: 35470438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term recovery In critical illness myopathy is complete, contrary to polyneuropathy.
    Koch S; Wollersheim T; Bierbrauer J; Haas K; Mörgeli R; Deja M; Spies CD; Spuler S; Krebs M; Weber-Carstens S
    Muscle Nerve; 2014 Sep; 50(3):431-6. PubMed ID: 24415656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to critical illness polyneuropathy and myopathy.
    Pati S; Goodfellow JA; Iyadurai S; Hilton-Jones D
    Postgrad Med J; 2008 Jul; 84(993):354-60. PubMed ID: 18716014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study.
    Frithiof R; Rostami E; Kumlien E; Virhammar J; Fällmar D; Hultström M; Lipcsey M; Ashton N; Blennow K; Zetterberg H; Punga AR
    Clin Neurophysiol; 2021 Jul; 132(7):1733-1740. PubMed ID: 33875374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weakness on the intensive care unit.
    Howard RS; Tan SV; Z'Graggen WJ
    Pract Neurol; 2008 Oct; 8(5):280-95. PubMed ID: 18796583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical illness polyneuropathy and myopathy in pediatric intensive care: A review.
    Williams S; Horrocks IA; Ouvrier RA; Gillis J; Ryan MM
    Pediatr Crit Care Med; 2007 Jan; 8(1):18-22. PubMed ID: 17251877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.